Similar articles

• Pharmacology of the serotonergic anxiolytic tandospirone (SM-3997).

  Seymour PA, Mena EE, McLean S, Heym J. Seymour PA, et al. Prog Clin Biol Res. 1990;361:453-60. Prog Clin Biol Res. 1990. PMID: 1981263 Review. No abstract available.
• Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.

  Stahl SM. Stahl SM. J Clin Psychiatry. 1997;58 Suppl 8:20-6. J Clin Psychiatry. 1997. PMID: 9236732 Review.
• Buspirone and related compounds as alternative anxiolytics.

  Taylor DP, Moon SL. Taylor DP, et al. Neuropeptides. 1991 Jul;19 Suppl:15-9. doi: 10.1016/0143-4179(91)90078-w. Neuropeptides. 1991. PMID: 1679210 Review.
• [The mechanisms of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives, serotonin agonists].

  Talalaenko AN, Kharin NA. Talalaenko AN, et al. Eksp Klin Farmakol. 1993 Mar-Apr;56(2):11-3. Eksp Klin Farmakol. 1993. PMID: 8102289 Russian.
• [Organic anxiety disorder].

  Shimoda K, Kimura M. Shimoda K, et al. Ryoikibetsu Shokogun Shirizu. 2003;(40):184-8. Ryoikibetsu Shokogun Shirizu. 2003. PMID: 14626097 Review. Japanese. No abstract available.